SCHEMBL3867327

SCHEMBL3867327

Cc1ccc(C(=O)Cn2c(=O)sc3ccccc32)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
TDP1 Q9NUW8 3/20 0.58
TSHR P16473 2/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPK1 P28482 1/20 0.58
GAA P10253 2/20 0.56
L3MBTL1 Q9Y468 6/20 0.55
TP53 P04637 1/20 0.55
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
HPGD P15428 1/20 0.54
CYP2C19 P33261 1/20 0.54
HTT P42858 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
CDYL2 Q8N8U2 2/20 0.52
CDYL Q9Y232 2/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13650902 0.85 NPC1 (0.57) SMN1; SMN2NPC1RAB9ATDP1TSHR
SCHEMBL10546592 0.77 L3MBTL1 (0.71) SMN1; SMN2NPC1RAB9ATDP1TSHR
SCHEMBL3866753 0.77 KMT2A (0.45) SMN1; SMN2NPC1RAB9ATDP1TSHR
SCHEMBL3866750 0.77 KMT2A (0.45) SMN1; SMN2NPC1RAB9ATDP1TSHR
SCHEMBL4616208 0.77 L3MBTL1 (0.77) SMN1; SMN2NPC1RAB9ATDP1TSHR
SCHEMBL10662788 0.76 L3MBTL1 (0.62) SMN1; SMN2RAB9ATDP1TSHRALDH1A1
SCHEMBL11348784 0.76 L3MBTL1 (0.60) SMN1; SMN2TDP1TSHRALDH1A1MAPK1
SCHEMBL2332474 0.76 L3MBTL1 (0.60) SMN1; SMN2TDP1TSHRALDH1A1MAPK1
SCHEMBL4616232 0.76 TDP1 (0.67) SMN1; SMN2RAB9ATDP1TSHRALDH1A1
SCHEMBL11740900 0.75 L3MBTL1 (0.65) SMN1; SMN2TDP1TSHRALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601846-B2 Compounds having activity as inhibitors of apoptosis THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-10-13 US disclosed
US-20060122178-A1 Compounds having activity as inhibitors of apoptosis REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE 2006-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122178-A1 Compounds having activity as inhibitors of apoptosis BAD, CASP3, BAX SMN1; SMN2 3506/4885NPC1 2532/4885RAB9A 3287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.